Episode 212: GU Oncology in 2023

By The Uromigos - January 3, 2023

Chris Sweeney, MBBS, director at the South Australian immunoGENomics Cancer Institute, joins The Uromigos to discuss 2022 highlights in GU oncology research as well as further research studies to be carried out in 2023, including the role of ADT with docetaxel for prostate cancer.

Post Tags:Uromigos-Prostate Cancer
Advertisement
Advertisement